The United States is a key market for the pharmaceutical industry, representing more than half of the revenue of Roche's ...

Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Two of Europe’s biggest drugmakers said they’re looking at ways to protect themselves from US President Donald Trump’s ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

Top Swiss officials will this week test whether big commitments to the U.S. can help secure relief from import tariffs, after ...

Switzerland’s top officials are expected to determine whether big commitments to the U.S. can help secure relief from Trump’s ...

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...

Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, ...